Featured
-
-
Research Highlight |
Nanoparticle-based pazopanib shows promise in OA
A nanoparticle-based formulation of the anticancer drug pazopanib, which inhibits VEGFR1 and VEGFR2, shows promise as a disease-modifying drug for osteoarthritis.
- Rebecca Kelsey
-
News & Views |
Limitations of the updated EULAR recommendations for osteoarthritis
EULAR’s 2023 updated recommendations for the non-pharmacological treatment of hip and knee osteoarthritis reiterates and confirms, in an abbreviated form, what we have known for more than a decade. Unfortunately, the abbreviated format of the updated recommendations lacks specificity and clinical usefulness. More detailed guidance could have facilitated wider uptake and improved care.
- Marius Henriksen
-
Research Highlight |
APOE in fat pad and synovium contributes to knee OA
New research has identified apolipoprotein E expressed by fibroblasts and macrophages in the infrapatellar fat pad and synovium as a pathogenetic mediator and potential therapeutic target in knee osteoarthritis.
- Robert Phillips
-
News & Views |
A critical view of WHO guidelines on management of low back pain
The World Health Organization (WHO) has published new guidelines for the non-surgical management of chronic primary low back pain in adults in primary and community care settings. Although the guidelines are commendable, they lack guidance on when to suspect and how to avoid missing important secondary causes of back pain.
- Mohamad Bittar
- & Atul Deodhar
-
Research Highlight |
Sodium channel Nav1.7 regulates chondrocyte biology and OA progression
The voltage-gated sodium channel Nav1.7 is expressed on chondrocytes, regulates chondrocyte biology and osteoarthritis progression, and is a promising dual target for modifying disease while providing pain relief in osteoarthritis.
- Jessica McHugh
-
News & Views |
Is cell therapy no better than steroid injection?
New findings suggest that current cell therapy approaches are not superior to a simple corticosteroid injection for the treatment of osteoarthritis, calling into question the role of existing cell therapies and highlighting the need for further research and development in this field.
- Scott A. Rodeo
-
Research Highlight |
Methotrexate improves pain in hand OA
Methotrexate reduces pain and stiffness in hand osteoarthritis with synovitis, according to the results of a new randomized controlled trial.
- Jessica McHugh
-
Review Article |
Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells
Extracellular vesicles derived from mesenchymal stromal cells provide the therapeutic benefits of the parental cells with advantages relating to immunogenicity and ease of handling. This Review discusses the therapeutic potential of native and modified extracellular vesicles for the treatment of rheumatic diseases, focusing on osteoarthritis and rheumatoid arthritis.
- Giuliana Minani Bertolino
- , Marie Maumus
- & Danièle Noël
-
Research Highlight |
Urchin-like nanoparticles for miRNA therapy of OA
Researchers have developed ‘urchin-like’ ceria nanoparticles with inherent antioxidant properties that efficiently carry therapeutic microRNA, enabling gene therapy following intra-articular injection in a mouse model of osteoarthritis.
- Robert Phillips
-
Review Article |
Heat of the night: sleep disturbance activates inflammatory mechanisms and induces pain in rheumatoid arthritis
In this Review the authors outline the evidence for how sleep disturbance and inflammation interact in a positive feedback spiral in rheumatoid arthritis, leading to further inflammation, pain and progression of disease activity.
- Michael R. Irwin
- , Rainer H. Straub
- & Michael T. Smith
-
Research Highlight |
Notch signalling mediates OA pain in mice
Notch signalling in the peripheral nervous system is involved in mediating pain in a mouse model of osteoarthritis.
- Jessica McHugh
-
Research Highlight |
Reprogramming autologous cells to treat OA
A new treatment for osteoarthritis that combines cells from the patient in vitro prior to intra-articular injection has demonstrated beneficial effects on arthritic joints in a compassionate use study.
- Robert Phillips
-
Research Highlight |
Targeting KDM2/7 histone demethylases could protect against OA
New research suggests that pharmacological restoration of H3K79 methylation could offer a way to prevent osteoarthritis onset and progression.
- Sarah Onuora
-
News & Views |
Osteoarthritis research is failing to reach consumers
Given that intra-articular injections for the knee of treatments such as hyaluronic acid, stem cells and platelet-rich plasma are advised against or only weakly recommended by current clinical-practice guidelines, why do people continue to seek information about these treatments?
- Vicky Duong
- & David J. Hunter
-
Research Highlight |
PPM1A: TGFβ regulator and therapeutic target in OA
Protein phosphatase magnesium-dependent 1A is a negative modulator of transforming growth factor β signalling and a potential new therapeutic target in osteoarthritis.
- Jessica McHugh
-
Research Highlight |
New biomarker panel best yet for prediction of OA progression
A panel of serum biomarkers identified by proteomic analysis outperforms the best current alternatives for prediction of the progression of osteoarthritis.
- Robert Phillips
-
Research Highlight |
Ageing matrix makes chondrocytes feel old
Age-related stiffening of the extracellular matrix in cartilage promotes chondrocyte ageing in an epigenetically controlled process involving repression of the longevity protein α-Klotho.
- Jessica McHugh
-
Research Highlight |
IKKε promotes catabolic responses in OA
IKKε, an upstream regulator of the NF-κB signalling pathway, mediates cartilage degradation in a mouse model of osteoarthritis and is a potential therapeutic target.
- Jessica McHugh
-
Research Highlight |
Draining OA from the synovium
New research suggests that impaired synovial lymphatic function contributes to the pathogenesis of age-related osteoarthritis and could represent a new therapeutic target.
- Sarah Onuora
-
-
Review Article |
Intervertebral disc degeneration and osteoarthritis: a common molecular disease spectrum
In this Review, the authors discuss the similarities and differences between intervertebral disc degeneration and osteoarthritis of the facet joint and argue that both diseases should be viewed as being part of the same molecular disease spectrum.
- Noah Fine
- , Starlee Lively
- & Raja Rampersaud
-
Research Highlight |
Fetuin-A peptide inhibits cartilage calcification
A calcium-binding peptide derived from fetuin-A inhibited pathological cartilage calcification in an experimental model of osteoarthritis, suggesting therapeutic potential.
- Sarah Onuora
-
Research Highlight |
Treg cell-inducing nanoparticles show promise for treating OA
Lipid nanoparticles loaded with type II collagen and rapamycin can induce antigen-specific regulatory T cell responses and alleviate disease in a mouse model of osteoarthritis.
- Jessica McHugh
-
Research Highlight |
‘Hyalinization’ for cartilage regeneration
A novel strategy for the repair of articular cartilage involves converting fibrocartilage to hyaline cartilage by modifying the cytoskeleton of fibrotic chondrocytes.
- Sarah Onuora
-
Review Article |
Cartilage calcification in osteoarthritis: mechanisms and clinical relevance
Cartilage calcification is a hallmark of osteoarthritis. In this Review, the authors discuss the molecular mechanisms of calcium crystal formation in chondrocytes, the effects of crystals on cells in the joint, and potential targets for the treatment of osteoarthritis and other calcification disorders.
- Ilaria Bernabei
- , Alexander So
- & Sonia Nasi
-
Research Highlight |
Single-cell-based platform maps response to candidate DMOADs
A new study demonstrates that a single-cell mass cytometry approach can provide a precise snapshot of how candidate drugs affect chondrocyte subpopulations from patients with osteoarthritis.
- Sarah Onuora
-
Research Highlight |
Aberrant regulation of autophagy linked to OA
Disruption of a newly identified axis involved in the regulation of autophagy in chondrocytes is implicated in osteoarthritis.
- Jessica McHugh
-
Research Highlight |
Lin28a blunts cartilage loss in a mouse model of OA
New research in a mouse model of osteoarthritis shows that the RNA-binding protein Lin28a is expressed in chondrocytes and limits cartilage damage by inhibition of Let-7 microRNAs.
- Robert Phillips
-
Research Highlight |
Targeting senescence in OA
New research demonstrates that a hydrogel-based miRNA delivery system might have therapeutic potential to treat osteoarthritis by targeting chondrocyte senescence.
- Michael Attwaters
-
Research Highlight |
Identifying OA subgroups based on biochemical data
A machine learning approach has been used to identify three distinct osteoarthritis endotypes based on biochemical markers related to joint tissue processes.
- Michael Attwaters
-
Research Highlight |
PGE2 receptor antagonist has potential to treat osteoarthritis
New research has identified the therapeutic potential of a small-molecule inhibitor of the prostaglandin E2 receptor EP4 against pathophysiology and pain in osteoarthritis.
- Robert Phillips
-
Review Article |
Synovial inflammation in osteoarthritis progression
This Review examines the biology of synovial inflammation, the cell types involved, their interactions and the role of synovitis in the development and progression of osteoarthritis.
- Elsa Sanchez-Lopez
- , Roxana Coras
- & Monica Guma
-
-
Review Article |
Erosive hand osteoarthritis: latest findings and outlook
Erosive hand osteoarthritis is an aggressive condition with poor outcomes. In this Review, the authors describe the clinical features and risk factors associated with erosive hand osteoarthritis, and summarize progress in the areas of biomarkers, imaging, classification criteria and treatment.
- Marta Favero
- , Elisa Belluzzi
- & Roberta Ramonda
-
Research Highlight |
Electric scaffolds charge cartilage repair
In a rabbit model of osteoarthritis, cartilage regeneration was promoted by a biodegradable implant that generates a piezoelectric response during physical exercise.
- Sarah Onuora
-
Review Article |
Joint-on-chip platforms: entering a new era of in vitro models for arthritis
In this Review, Paggi et al. discuss the requirements and challenges in engineering a joint-on-chip device, propose an architecture for such a model of the joint and highlight the potential for these platforms to further advance insight into arthritic diseases and facilitate drug development.
- Carlo Alberto Paggi
- , Liliana Moreira Teixeira
- & Marcel Karperien
-
Research Highlight |
Use of platelet-rich plasma for knee OA not supported by RCT results
In a rigorous randomized controlled trial, treatment with platelet-rich plasma did not improve knee osteoarthritis symptoms or slow disease progression.
- Sarah Onuora
-
Review Article |
Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis
The pathways involved in sensing and responding to mechanical stimuli have important roles in maintaining cartilage health, and can contribute to disease when dysregulated. This Review discusses cartilage mechanosignalling pathways and how they can be targeted to treat osteoarthritis.
- Tom Hodgkinson
- , Domhnall C. Kelly
- & Fergal J. O’Brien
-
-
Research Highlight |
Articular cartilage hypoxia is a potential target for OA therapy
Researchers have found that hypoxia in articular cartilage is associated with expression of DOT1L, which protects against cartilage damage in a mouse model of osteoarthritis.
- Robert Phillips
-
Research Highlight |
Inhibition of epoxide hydrolysis targets pain in osteoarthritis
Inhibition of the soluble epoxide hydrolase enzyme prevents metabolism of anti-inflammatory epoxyeicosatrienoic acids and reduces pain in a mouse model of osteoarthritis.
- Robert Phillips
-
-
Research Highlight |
Restoring cartilage lubrication to heal post-traumatic OA
A study published in Nature Biomedical Engineering reports a new biomimetic lubricant that can help restore cartilage in rats with post-traumatic osteoarthritis.
- Joanna Clarke
-
Review Article |
Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms
Knee joint distraction (KJD) is used to stimulate joint repair in advanced osteoarthritis. In the Review, Jansen and Mastbergen provide an overview of the clinical trial results of KJD treatment, current knowledge of the molecular mechanisms underlying joint repair in KJD, and future directions and unanswered questions in KJD research and treatment.
- Mylène P. Jansen
- & Simon C. Mastbergen
-
Review Article |
The non-coding RNA interactome in joint health and disease
Non-coding RNAs such as microRNAs, long non-coding RNAs and circular RNAs regulate signalling pathways that are important in joint development, homeostasis and disease. A better understanding of the non-coding RNA interactome could lead to new therapies for joint diseases.
- Shabana A. Ali
- , Mandy J. Peffers
- & Mohit Kapoor
-
Research Highlight |
Nasal chondrocytes enable cartilage repair in OA joints
New research shows that cartilage engineered from nasal chondrocytes can integrate with osteoarthritic joint tissues in animal models, and provides early evidence of clinical benefits in patients with knee osteoarthritis.
- Robert Phillips
-
-
Research Highlight |
Targeting articular Mmp13 in OA
Targeted nanoparticles that bind to exposed type II collagen in injured joints and promote localized downregulation of Mmp13 expression represent progress towards a disease-modifying osteoarthritis drug.
- Robert Phillips
-
Review Article |
Early-stage symptomatic osteoarthritis of the knee — time for action
In this Review, the authors assess the current understanding of symptomatic early-stage knee osteoarthritis, including its diagnosis and classification, and highlight important gaps in knowledge that will need to be addressed to enable effective management.
- Armaghan Mahmoudian
- , L. Stefan Lohmander
- & Frank P. Luyten